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Lead is a multi-organ toxicant implicated in various cancers, diseases of the hepatic,
renal, and reproductive systems etc. In search of cheap and readily available antidote
this study has investigated the role of activated charcoal in chronic lead exposure in
albino rats. Eighteen mature male albino rats were used, divided into three groups
of six rats per group. Group 1 (control rats) received deionised water (10 ml/kg),
group 2 was given lead acetate solution 60 mg/kg and group 3 rats were given lead
acetate (60 mg/kg) followed by Activated charcoal, AC (1000 mg/kg) by oral gavage
daily for 28 days. Rats in group 2 showed significant increases in serum Aspartate
aminotransferase, Alkaline phosphatase, Alanine aminotransferase, urea, bilirubin, total
cholesterol, triglycerides, Low Density Lipoprotein, Very Low Density Lipoproteins, Total
White Blood Cell Counts, Malondialdehyde, Interleukin-6, and decreases in Packed
Cell Volume, hemoglobin concentration, Red blood cell count, total proteins, albumins,
superoxide dismutase, glutathione peroxidase and total glutathione. Co-administration
of AC significantly decreased these biomarkers with the exception of the sperm
parameters. Histopathology of liver and kidney also confirmed the protective effective
of AC against lead induced hepato-renal damage. AC may be beneficial in chronic lead
induced liver and kidney damage.
Keywords: chronic lead toxicity, activated charcoal, hepato-renal damage, biomarkers, public health
INTRODUCTION
Lead constitute an integral source of poisoning to the ecosystem. It primarily affects the central
nervous system, hematopoietic, hepatic and renal system, producing serious disorders (Kalia and
Flora, 2005). Lead exposure also causes anemia, immunotoxicity and toxicity to the reproductive
organs (WHO, 2016). Excessive dietary intake of lead has been linked with cancers of stomach,
small intestine, large intestine, ovary, kidney, lungs, myeloma, all lymphomas, and all leukemia
(Reddy et al., 2004). Studies in general populations have identified a positive association of lead
exposure with coronary artery disease (CAD), stroke mortality, and peripheral arterial disease
(Lustberg and Silbergel, 2002; Prozialeck et al., 2008). Lead has also been reported of causing
impairment of the quality of semen in the male reproductive system (Eibensteiner et al., 2005;
Telisman et al., 2007). There is no known safe blood lead concentration. Even blood lead
concentration as low as 5 µg/dL, once thought to be a safe level, may result in decreased intelligence
in children, behavioral difficulties and learning problems (WHO, 2016).
Developing nations are particularly of high risk to lead poisoning and carry the highest burden
of this hazard. In Nigeria, a suspected case of lead poisoning which occurred at Unguwan Magiro
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and Unguwan Kawo communities in Rafi Local Government Area
of Niger state in which 48 cases mostly children, (with BLL
between 171.5–224 µg/dL) including 14 deaths were reported
in May 15, 2015 (WHO, 2015). In March, 2010, Medecins
Sans Frontieres, MSF/Doctors without Borders, an international,
independent, medical humanitarian organization was alerted to
a high number of child fatalities in Zamfara state, northern
Nigeria. An estimated 400 children died. Laboratory testing later
confirmed high levels of lead in the blood of the surviving
children. The root cause of the lead poisoning crisis was unsafe
mining and ore processing (Medecins Sans Frontieres [MSF],
2012). Artisanal gold mining as well as agriculture are the
predominant occupations in the affected communities. Lead
poisoning from Lead-acid battery recycling was also reported
in Dakar, Senegal (WHO, 2010). The current drug treatment
of lead poisoning is Chelation Therapy with drugs such as
Dimercaprol, Ethylenediaminetetraacetic acid (EDTA), Succimer
and D-penicillamine (Cuprimine) (Kessel and O’Connor, 2001).
Activated charcoal is a light, finely divided, black fluffy powder
prepared by pyrolysis of carbonaceous material such as wood,
coconut shells, or petroleum and oxidation using steam or
air at high temperature (600–900◦C) (Orisakwe, 1994; Cooney,
1995; Olson, 2010; Vaziri et al., 2013). It adsorbs a wide range
of substances and organisms (Cooney, 1995). According to
Cooney (1995), the adsorption of most metals including lead to
activated charcoal is poor and consequently it is seldom used in
management of lead poisoning. While AC is mainly associated
with treatment of poisoning substances, it has other important
roles in the treatment of patients with chronic kidney disease
which enhances the outcome of renal dialysis (Alkhatib and Al
Zailaey, 2015).
Many antidotes are biological products and their cost,
methods of production, potential for eliciting immunogenic
responses, the time needed to generate them, and stability
issues contribute to their limited availability and effectiveness.
These factors exacerbate a world-wide challenge for providing
treatment (Weisman et al., 2015). In resource poor nations of sub
Saharan Africa with rampant lead poisoning, the cost of chelation
therapy is considered prohibitive. There is a need therefore to
explore readily available and natural antidotes in the management
of lead poisoning. Hitherto there is sparse information on the
in vivo adsorptive capacity of activated charcoal on lead (Cheong
and Roh, 2006). The present study seeks to add to the fund
of knowledge for the clarification of the usefulness of activated
charcoal in the management of the hepato-renal complications of
chronic lead exposure since available data so far have focused on
acute lead exposure.
MATERIALS AND METHODS
Materials
Chemicals
Lead acetate trihydrate (May & Baker, England), Activated
Charcoal, AC (Merck KGaA, Darmstadt, Germany). Lead acetate
salt was dissolved in deionised water, while AC was dispersed in
deionised water to form a suspension.
Animal Husbandry
Eighteen mature male albino Wistar rats, weighing 145–170 g
obtained from the University of Uyo Animal house, were
acclimatized for 2 weeks, maintained under controlled conditions
of temperature (23 ± 2◦C) and humidity (50 ± 5%) and a 12-h
light–dark cycle, were used for the experiment. The animals were
housed in sanitized polypropylene cages containing sterile paddy
husk as bedding. The bedding of the cages was changed daily
and the cages were cleaned as well. They had free access to
standard rat pellet diet and water ad libitum. The procedures were
performed according to the guidelines on the use of animals and
approved by the Institutional Animal Ethical Committee of the
University of Uyo.
Experimental Design
The animals were divided into three groups of six rats per group
as follows: The animals were treated as follows;
Group 1 – Normal control received deionised water 10 ml/kg
by oral gavage daily for 28 days in addition to standard feed
and water.
Group 2 – Lead acetate solution 60 mg/kg by oral gavage daily
for 28 days addition to standard feed and water (Cheong and
Roh, 2006).
Group 3 – Lead acetate (60 mg/kg) (Cheong and Roh, 2006),
followed by Activated charcoal AC (1000 mg/kg) by oral gavage
daily for 28 days (American Society for the Prevention of
Cruelty to Animals [ASPCA], 2015). In all animals received
activated charcoal 90 min after administration of lead (Olson,
2010).
Necropsy
Treatments continued for 28 days. Blood was collected
by retro orbital sinus puncture (Stone, 1954). Each blood
sample was divided into two portions. The first one was
mixed well with the anticoagulant, dipotassium EDTA
by shaking and used for hematological screening. The
second portion (without anticoagulant) was kept at room
temperature for 30 min to clot. Afterward, the clotted blood
sample was centrifuged at 3,000 rpm for 10 min. The clear
serum supernatant was then carefully aspirated and stored
in a clean sample bottle for the determination of some
biochemical parameters. Rats were sacrificed under ether
anesthesia (Okolo et al., 2016) and concussion stunning
involving manually applied trauma on the head (AVMA,
2013); the kidney and liver were excised, weighed, rinsed in
saline, and preserved in 10% formalin for histopathological
study.
Hematological Screening
Total White Blood Cell Counts (TWBC), Packed Cell
Volume (PCV), Red blood cell (RBC) count, Lymphocytes
% (L%) and Neutrophils % (N%) were determined using the
Hemocytometer method (Thrall and Weiser, 2002). Hemoglobin
(Hb) concentration was determined by the Cyanmethemoglobin
method (Higgins et al., 2008).
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Biochemical Analysis
Total serum bilirubin (Doumas et al., 1973), serum total proteins
(Lubran, 1978), serum Albumins (Doumas and Peters, 1997),
serum Globulin (calculated by subtracting the quantity of
albumins from that of total proteins), serum total cholesterol
(Allain et al., 1974), High Density Lipoprotein (HDLs) (Albers
et al., 1978), Low Density Lipoprotein (LDL) and Very Low
Density Lipoproteins (VLDL) (Friedewald et al., 1972; Warnick
et al., 1990), serum triglycerides (Bucolo and David, 1973), serum
creatinine (Blass et al., 1974) and serum urea (Fawcett and Scott,
1960) and Searcy et al. (1967) were determined. The following
liver enzymes were also assayed: Alanine Aminotransferase
(ALT) and Aspartate aminotransferase (AST) (Reitman and
Frankel, 1957) and Alkaline phosphatase (ALP) (Babson et al.,
1966).
Antioxidants Study and Assessment of Lipid
Peroxidation/Oxidative Stress
Determination of Antioxidant Levels Namely
(i) Superoxide dismutase (SOD) in whole blood using
Superoxide Dismutase kit in accordance with
manufacturer’s recommended protocols (Fortress
Diagnostics Limited, UK).
(ii) Glutathione peroxidase (GSH-PX) in whole blood
using Glutathione peroxidase kit in accordance with
manufacturer’s recommended protocols (Fortress
Diagnostics Limited, UK).
(iii) Plasma Total Glutathione using RayBio R© Glutathione
Colorimetric Detection Kit in accordance with
manufacturer’s recommended protocols (RayBiotech,
Inc. USA)
(iv) Measurement of Malondialdehyde (MDA), a prototype
of the thiobarbituric reactive substances (TBARS) as a
biomarker of lipid peroxidation and oxidative stress using
the modified thiobarbituric acid method (Todorova et al.,
2005).
Determination of Serum Levels of Pro-Inflammatory
Cytokines
Serum levels of pro-inflammatory cytokines (Tumor necrosis
factor-alpha, TNF-α) and Interleukin-6 (IL-6) were determined
using rat ELISA (Enzyme-linked immunosorbent assay) kits
in accordance with manufacturer’s recommended protocols
(RayBiotech, Inc. USA and Assaypro LLC, USA).
Statistical Analysis
Results were expressed as mean ± standard deviation, SD.
Statistical analysis was carried out with one way analysis of
variance (ANOVA) followed by Tukey’s HSD post hoc test. Values
of p < 0.05 were considered to be significant.
RESULTS
Effect of Activated Charcoal on
Hematological Parameters
Treatment of rats with lead acetate (Group 2) caused significant
(p < 0.05) decreased in PCV, Hb concentration and RBC
count when compared with normal control. These decreased
parameters were increased significantly (p < 0.05) in group 3
animals which were given Activated charcoal after lead acetate
treatment. Rats in group 2 (given lead acetate only) also had
significant increase (p < 0.05) in total white blood count (WBC)
when compared to rats in the normal control group (Group
1), while the total WBC in group 3 animals was significantly
(p < 0.05) decreased. There was no effect on lymphocyte and
neutrophil percentages (Table 1).
Effect of Activated Charcoal on
Biochemical Parameters
Table 2 show the effect of activated charcoal on the serum
levels of AST, ALP, and ALT in lead acetate-treated male albino
Wistar rats. Treatment of rats with lead acetate (group 2) caused
significant (p < 0.05) increase in the following liver enzymes
when compared with the normal control group (group 1): AST,
ALP, and ALT. These enzymes decreased significantly (p < 0.05)
in group 3 animals which were given activated charcoal after lead
acetate treatment (Table 2).
The effect of activated charcoal on serum total proteins,
Albumins, Globulins, Urea, Creatinine, and Bilirubin in lead
acetate-treated male albino Wistar rats is shown on Table 3. There
was significant (p < 0.05) decrease in serum total proteins and
albumins in rats in group 2 compared to rats in group 1. These
two parameters increased significantly (p < 0.05) in group 3
TABLE 1 | Effect of Activated charcoal on the hematological parameters of lead acetate-treated male albino Wistar rats.
Treatment Packed cell
volume, PCV (%)
Hemoglobin, Hb
concentration (g/dl)
Red blood cell count,
RBC (106/µL)
Total WBC count
(103/µL)
Lymphocyte
(%)
Neutrophil
(%)
Group 1: Deionised water
(10 ml/kg)
40.67 ± 1.63 16.31 ± 0.72 7.89 ± 0.18 19.24 ± 4.85 71.00 ± 3.35 26.83± 3.55
Group 2: Lead acetate
(60 mg/kg)
32.83 ± 1.29a 12.57 ± 0.66a 4.41 ± 1.05a 30.66 ± 3.40a 77.00 ± 6.42 26.33± 1.51
Group 3: Lead acetate
(60 mg/kg) + AC
(1000 mg/kg)
38.75 ± 0.42b 15.47 ± 0.42b 7.45 ± 0.52b 18.12 ± 4.70b 69.00 ± 559 26.83± 2.93
Data were expressed as mean ± SD. aSignificantly different when compared to the control group (p < 0.05). bSignificantly different when compared to the lead acetate-
treated group (p < 0.05) (n = 6).
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animals given activated charcoal after lead acetate treatment. The
serum level of globulin was not significantly affected (Table 3).
There was a significant increase (p < 0.05) in the following
parameters: urea and bilirubin in group 2 animals compared
to that of rats in the normal control group (group 1). These
parameters decreased significantly (p < 0.05) in group 3 animals.
However, there was no significant effect (p > 0.05) on creatinine
level.
On the lipid profiles, rats in group 2 showed significant
(p < 0.05) increase in total cholesterol, triglycerides, LDL and
VLDL, compared to those in the control group. These parameters
were significantly (p < 0.05) reduced in group 3 animals except
for VLDL. There was no significant effect (p > 0.05) on HDL
values (Table 4).
Table 5 shows the effect of activated charcoal on
some antioxidant, lipid peroxidation parameters and
pro-inflammatory cytokines of Lead acetate-treated male
albino Wistar rats.
Treatment of rats with lead acetate (group 2) caused
significant (p < 0.05) decrease in the following antioxidant
enzymes/parameters: GSH-PX, SOD, and Total Glutathione
when compared with the normal control group (group 1). These
parameters were significantly (p < 0.05) increased in group 3
animals. Also, the value of the biomarker of lipid peroxidation,
MDA was significantly (p < 0.05) increased in group 2 rats,
compared to those in the normal control group (group 1). This
biomarker was significantly (p < 0.05) decreased in group 3. Rats
in group 2 showed significant (p < 0.05) increase in the pro-
inflammatory cytokine, IL-6 in comparison with normal control
(group 1). Level of this cytokine was significantly (p < 0.05)
decreased in group 3. However, there was no effect on the serum
level of another pro-inflammatory cytokine, TNF-α.
Histopathology of the Kidney and liver:
Liver
The histological photomicrograph of the liver tissue stained with
H&E techniques of Group 1 – control that received deionised
water 10 ml/kg by oral gavage daily for 28 days is shown on
Figures 1A,B. Central veins with normal intact hepatocytes
surrounding it (1A Mag × 160). Figures 1C,D show the
histological photomicrograph of the liver tissue stained with H&E
techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days.
Liver samples from group 2 (lead acetate-treated group) were
observed to have massive cellular (neutrophils and lymphocytes)
infiltrations around the peri-portal areas, some hepatocyte
necrosis and there was also vacuolations/vacuolar degeneration
of peripheral hepatocytes (Figures 1C,D). Figures 1E,F,G show
the Histological photomicrograph of the liver tissue stained with
H&E techniques of Group 3 – Lead acetate (60 mg/kg) followed
by AC (1000 mg/kg) daily for 28 days. There was no vacuolar
TABLE 2 | Effect of activated charcoal on the serum levels of Aspartate aminotransferase (AST), Alkaline phosphatase (ALP) and Alanine
aminotransferase (ALT) in Lead acetate-treated male albino Wistar rats.
Treatment AST (U/L) (U/L) ALP (U/L) ALT (U/L)
Group 1: Deionised water (10 ml/kg) 55.77 ± 0.88 180.79 ± 0.17 17.67 ± 2.05
Group 2: Lead acetate (60 mg/kg) 76.77 ± 9.20a 211.71 ± 9.63a 35.53 ± 2.82a
Group 3: Lead acetate (60 mg/kg) + AC (1000 mg/kg) 53.82 ± 5.93b 183.31 ± 15.07b 19.39 ± 5.00b
Data were expressed as mean ± SD. aSignificantly different when compared to the control group (P < 0.05). bSignificantly different when compared to the lead acetate-
treated group (P < 0.05) (n = 6).
TABLE 3 | Effect of activated charcoal on serum total proteins, albumins, globulins, urea, creatinine, and bilirubin in lead acetate-treated male albino
Wistar rats.
Treatment Total proteins
(g/dl)
Albumins
(g/dl)
Globulins
(g/dl)
Urea
(mg/dl)
Creatinine
(mg/dl)
Bilirubin
(mg/dl)
Group 1: Deionised water (10 ml/kg) 8.55 ± 0.34 4.28 ± 0.38 4.27 ± 0.35 17.92± 2.83 0.59 ± 0.08 0.27 ± 0.11
Group 2: Lead acetate (60 mg/kg) 6.61 ± 0.16a 2.90 ± 0.17a 3.71 ± 0.25 29.00± 3.23a 0.64 ± 0.05 0.97 ± 0.31a
Group 3: Lead acetate (60 mg/kg) +
AC (1000 mg/kg)
7.76 ± 0.32ab 3.90 ± 0.14b 3.84 ± 0.38 18.91± 1.47b 0.56 ± 0.05 0.35 ± 0.10b
Data were expressed as mean ± SD. aSignificantly different when compared to the control group (P < 0.05). bSignificantly different when compared to the lead
acetate-treated group (p < 0.05) (n = 6).
TABLE 4 | Effect of activated charcoal on lipid profiles of lead acetate-treated male albino Wistar rats.
Treatment Total cholesterol (mg/dl) HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl) Triglyceride (mg/dl)
Group 1: Deionised water (10 ml/kg) 53.29 ± 5.57 22.16 ± 6.22 26.30 ± 9.21 4.94 ± 0.47 24.17 ± 2.84
Group 2: Lead acetate (60 mg/kg) 78.51 ± 13.66a 22.62 ± 5.00 40.07 ± 4.92a 22.64 ± 12.64a 113.20 ± 63.17a
Group 3: Lead acetate (60 mg/kg) + AC (1000 mg/kg) 55.03 ± 5.74b 20.56 ± 3.30 26.06 ± 1.51b 10.69 ± 4.55 45.70 ± 20.39b
Data were expressed as mean ± SD. aSignificantly different when compared to the control group (P < 0.05). aSignificantly different when compared to the lead
acetate-treated group (P < 0.05) (n = 6).
Frontiers in Pharmacology | www.frontiersin.org 4 March 2017 | Volume 8 | Article 107
fphar-08-00107 March 11, 2017 Time: 13:38 # 5
Offor et al. Activated Charcoal on Lead Induced Hepato-renal Damage
TABLE 5 | Effect of activated charcoal on some antioxidant, lipid peroxidation parameters and pro-inflammatory cytokines of lead acetate-treated male
albino Wistar rats.
Treatment Malondialdehyde
(µmol/L of
plasma)
Glutathione
peroxidase (U/L of
blood)
Superoxide
dismutase (U/ml of
blood)
Total glutathione
(ng/µL)
Interleukin-6
(IL-6)
Tumor necrosis
factor-alpha
(TNF-α)
Group 1: Deionised
water (10 ml/kg)
1.58 ± 0.09 482.85 ± 53.43 144.80 ± 7.00 1.11 ± 0.03 74.41 ± 5.45 0.01 ± 0.00
Group 2: Lead acetate
(60 mg/kg)
1.90 ± 0.17a 247.18 ± 70.40a 122.39 ± 4.63a 0.56 ± 0.31a 113.58± 13.46a 0.00 ± 0.00
Group 3: Lead acetate
(60 mg/kg) + AC
(1000 mg/kg)
1.62 ± 0.14b 327.65 ± 96.32 142.13 ± 8.82b 1.20 ± 0.08b 72.68+11.68b 0.00 ± 0.00
Data were expressed as mean ± SD. aSignificantly different when compared to the control group (P < 0.05). bSignificantly different when compared to the lead
acetate-treated group (P < 0.05) (n = 6).
degeneration of peripheral hepatocytes (intact hepatocytes) and
mild cellular infiltration with few lymphocytes around the portal
areas
Kidney
Figure 2 shows the histological photomicrograph of the kidney
stained with H&E techniques of Group 1 – control that received
deionised water 10 ml/kg by oral gavage daily for 28 days
(Figures 2A,B). There was normal dilated tubules and glomeruli
at the periphery of the cortex. Group 2 – Lead acetate 60 mg/kg
daily for 28 days –Degeneration and necrosis of the renal
parenchymal cells with massive inflammatory cells infiltration
(2C Mag × 160). The kidney of rats in Group 2 – Lead acetate
60 mg/kg daily for 28 days showed areas of degeneration and
necrosis of the renal cortical parenchymal cells with massive
lymphocytic cellular infiltration, with vacuolation/vacuolar
degeneration of the peripheral interstitial cells of the cortex
(Figures 2C,D).Tissue sections from the kidneys of rats in Group
3 – Lead acetate (60 mg/kg) followed by AC (1000 mg/kg) daily
for 28 days had varied areas of normal and degenerated cortical
tubules, with mild cellular infiltration of the renal parenchyma
(Figures 2E,F).
DISCUSSION
Lead is one of the most toxic heavy metals of great public health
significance. Exposure to low-level heavy metals such as lead
may contribute much more toward the causation of chronic
diseases (diabetes, renal disease, cancer, male infertility etc.) and
impaired functioning than previously thought (Orisakwe, 2014).
Chelators, the currently available antidote for the treatment of
lead poisoning have many adverse effects such as being painful,
hepatotoxicity, gastrointestinal symptoms, among others. In
addition to difficulties in the administration of some chelators,
they are also expensive and not readily available. Also, chelation
therapy is recommended by the CDC to be used only in extreme
cases where the blood lead level is over 45 ug/dL. It is generally
not used in cases where levels are under 25 ug/dl and it neither
removes all of the lead from the body nor does it undo damage
already done to organ. Activated charcoal is thus investigated in
this study as a possible alternative to the classical antidotes owing
to the aforementioned limitations. As a further justification for
this research, there is currently sparse information on the in vivo
efficacy of AC in the treatment of lead poisoning.
In this study, treatment of rats with lead acetate caused
significant increase in the activity of serum AST, ALT, ALP,
bilirubin and urea, while the levels of albumin and total proteins
were decreased. Similar results were reported by Azoz and Raafat
(2012), Ibrahim et al. (2012), and Azab (2014). These parameters
were, however, reversed by treatment with activated charcoal
in this study. Increasing levels of AST and ALT in the lead
acetate-treated rats signify damage to the structural integrity
of the liver. It is mainly due to the leakage of these enzymes
from the liver cytosol into the blood stream (Concepcion et al.,
1993). Releasing of AST and AST from the cell cytosol can
occur as secondary changes to cellular necrosis (Gaskill et al.,
2005). The high AST and ALT activities are accompanied by high
liver microsomal membrane fluidity, free radical generation and
alteration in the liver tissue (Ibrahim et al., 2012). Elevated level
of ALP suggests biliary damage or an obstruction of the biliary
tree, which disrupts the flow of blood to the liver (Farida et al.,
2012). The decrease in serum levels of these enzymes may be
due to the prevention of their leakage from the liver cytosol by
activated charcoal, probably due to reduction in blood lead level.
The increase of bilirubin values in rats treated with lead acetate
in this study may be due to excessive heme destruction and
blockage of biliary tract resulting in inhibition of the conjugation
reaction and release of unconjugated bilirubin from damaged
hepatocytes (Ali et al., 2010). Bilirubin has a protective role
against oxidative damage of cell membrane induced by metal
(Noriega et al., 2003).
Lead acetate administration in this study caused significant
increase in serum urea level, but only a slight increase in serum
creatinine level. The serum urea was significantly decreased
with the administration of activated charcoal in this study but
showed only a slight decrease in the value of creatinine after
28 days. This is in agreement with the work of Cheong and Roh
(2006), whose data showed a significant decrease in the value of
blood urea nitrogen after 1 week of administration of activated
charcoal, while the serum level of creatinine was only significantly
reduced by activated charcoal after 72 h. This study confirms the
conclusion by Cheong and Roh (2006) that activated charcoal
may protect the lead-induced toxicity on kidney.
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FIGURE 1 | (A) Histological photomicrograph of the liver tissue stained with H&E techniques of Group 1 – control that received deionised water 10 ml/kg by oral
gavage daily for 28 days – Central veins with normal intact hepatocytes surrounding it (1A Mag × 160). (B) Histological photomicrograph of the liver tissue stained
with H&E techniques of Group 1 – control that received deionised water 10 ml/kg by oral gavage daily for 28 days – Intact hepatocytes on the periphery (no
vacuolations – 1B Mag × 640). (C) Histological photomicrograph of the liver tissue stained with H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for
28 days – Massive cellular infiltration around the portal areas with some hepatocyte necrosis (1C Mag × 160). (D) Histological photomicrograph of the liver tissue
stained with H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days – Vacuolation or vacuolar degeneration of peripheral hepatocytes (1D
Mag × 640). (E) Histological photomicrograph of the liver tissue stained with H&E techniques of Group 3 – Lead acetate (60 mg/kg) followed by AC (1000 mg/kg)
daily for 28 days – Mild cellular infiltration around the portal areas (1E Mag × 160). (F) Histological photomicrograph of the liver stained with H&E techniques of
Group 3 – Lead acetate (60 mg/kg) followed by AC (1000 mg/kg) daily for 28 days – Mild cellular infiltration with few lymphocytes around the portal areas (1F
Mag × 640). (G) Histological photomicrograph of the liver stained with H&E techniques of Group 3 – Lead acetate (60 mg/kg) followed by AC (1000 mg/kg) daily for
28 days – Intact hepatocyte.
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FIGURE 2 | (A) Histological photomicrograph of the kidney stained with H&E techniques of Group 1 – control that received deionised water 10 ml/kg by oral gavage
daily for 28 days – normal dilated tubules and glomeruli at the periphery of the cortex (2A Mag × 160). (B) Histological photomicrograph of the kidney stained with
H&E techniques of Group 1 – control that received deionised water 10 ml/kg by oral gavage daily for 28 days – normal renal cortical tubules and glomeruli (2B
Mag × 640). (C) Histological photomicrograph of the kidney tissue stained with H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days –
Degeneration and necrosis of the renal parenchymal cells with massive inflammatory cells infiltration (2C Mag × 160). (D) Histological photomicrograph of the kidney
tissue stained with H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days – Massive lymphocytic cellular infiltration, with degeneration and necrosis
(2D Mag × 640). (E) Histological photomicrograph of the kidney stained with H&E techniques of Group 3 – Lead acetate (60 mg/kg) followed by AC (1000 mg/kg)
daily for 28 days –showing normal medullary tubules (2E Mag × 160). (F) Histological photomicrograph of the kidney stained with H&E techniques of Group 3 – Lead
acetate (60 mg/kg) followed by AC (1000 mg/kg) daily for 28 days – some degenerated tubules and mild cellular infiltration of the renal parenchyma(2F Mag × 640).
Charcoal in various forms administered with low protein diets
has been reported to control effectively some uremic symptoms
in patients with different stages of renal disease, and this is
achieved through the binding of urea and other urinary toxins
to charcoal, and its excretion with feces, creating a concentration
gradient for continued diffusion of these toxins (Ash, 2009).
Simultaneous treatment of rats with adenine and AC (20% w/w in
the feeds for 28 days) has been shown to produce a broad, dose-
dependent, nephroprotective action in adenine-induced chronic
Renal failure (Ali et al., 2014). Also in this study, lead acetate
caused a significant decrease in the values of serum total proteins
and Albumins. Administration of activated charcoal in this study
was able to significantly increase these parameters. Decrease in
serum total protein may be due to both hepatic and renal damage
induced by lead (Ahmed and Shalaby, 1999), or may be due to
binding of lead to plasma proteins, where it causes alteration in
a high number of enzymes and can also disturb protein synthesis
in hepatocytes (Goering, 1993). Decreasing of serum total protein
values may be attributed to a decrease in hepatic DNA and RNA
induced by lead intoxication or due to decreased utilization of
free amino acids for protein synthesis (Moussa and Bashandy,
2008).
In our study, administration of lead acetate was found to
cause elevation of Total cholesterol, triglycerides, LDL and VLDL.
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These parameters were reduced by treatment with activated
charcoal. The result is in agreement with the report of Azoz
and Raafat (2012). The high lipid levels could be due to
either increased synthesis or decreased removal of lipoproteins.
Decreased removal may occur as a result of the alteration of
cell – surface receptors for lipoprotein (Tarugi et al., 1982) or
as a result of the inhibition of hepatic lipoprotein lipase activity
(Chajet et al., 1989). Furthermore, lead has been shown to depress
the activity of cytochrome P – 450 (Alvares et al., 1975), this can
limit the biosynthesis of the bile acids, which is the significant
route for elimination of cholesterol from the body. Although
activated charcoal did not show any significant effect on HDL in
this study, AC significantly lowered lead induced increase in LDL,
triglycerides and total cholesterol implicated in the development
of heart disease.
It was observed in this study that levels of total glutathione,
SOD, GSH-PX were significantly reduced in lead acetate-treated
rats. The values of these biomarkers were increased by the
protective activity of activated charcoal, which also significantly
reduced the value of the lead acetate-induced biomarker of lipid
peroxidation, MDA. This result is in agreement with the report of
Azoz and Raafat (2012). Oxidative stress represents an imbalance
between the production of free radicals and the biological
system’s ability to readily detoxify the reactive intermediates
or to repair the resulting damage (Flora, 2011). It has been
reported as a major mechanism of lead induced toxicity (Flora
et al., 2012). Under the influence of lead, onset of oxidative
stress occurs on account of two different pathways operative
simultaneously. First, the generation of reactive oxygen species,
ROS and second, the antioxidant reserves become depleted
(Flora, 2002). Apart from targeting the sulfhydryl groups, lead
can also replace the zinc ions that serve as important cofactors
for these antioxidant enzymes and inactivate them (Flora et al.,
2007). Lipid peroxidation, another indicator of oxidative stress
occurs as a result of the action of ROS on lipid membranes. The
generated free radical captures electrons from the lipids present
inside the cell membranes and damages the cell.
Treatment of rats with lead acetate in this study caused
significant reduction in PCV, Hb concentration and RBC count.
Our results were in agreement with Azoz and Raafat (2012)
and Ibrahim et al. (2012). On the other hand, total WBC
was significantly increased. Administration of activated charcoal
significantly reversed these parameters. Lead directly affects
the hematopoietic system through restraining the synthesis of
Hb by inhibiting various key enzymes involved in the heme
synthesis pathway, particularly the enzyme Aminolevulinic Acid
Dehydratase (ALAD). It also reduces the life span of circulating
erythrocytes by increasing the fragility of cell membranes. The
aftermath of these two processes leads to anemia (Guidotti et al.,
2008; Flora et al., 2012).
Administration of lead acetate caused significant increase in
the pro-inflammatory cytokine, IL-6. However, administration
of activated charcoal significantly reduced the level of IL-6. AC
could protect from lead acetate-induced toxicity by attenuating
the increased serum IL-6. However, the exact mechanism through
which it is achieved requires further investigation. Howell
et al. (2013), have reported good removal of the inflammatory
cytokines IL-8 (100% removal), IL-6 (80% removal) and TNF-α
(51% removal) from blood using nanoporous activated carbon
beads. In another experiment, Inoue et al. (2015) concluded that
AC should be efficient for cytokine adsorption. Measurements
of humoural factors such as cytokines and other inflammatory
mediators or markers can provide predictive clinical information
plus insights into disease mechanisms (Zhou et al., 2010).
Taken together activated charcoal seems to be protective
against hepato-renal damage induced by chronic exposure of
lead in the animal model. The elevation of antioxidant enzymes
level, reduction of lipid peroxidation (MDA), modulation of the
pro-inflammatory cytokine, IL-6; and reversal of lead-induced
alteration in some hematological and biochemical parameters
following administration of AC may be as result of decrease
in blood lead level BLL, Further studies may be necessary to
understand the precise mechanism of action.
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